ResMed
325 hedge funds and large institutions have $5.26B invested in ResMed in 2015 Q1 according to their latest regulatory filings, with 50 funds opening new positions, 101 increasing their positions, 124 reducing their positions, and 30 closing their positions.
76% more call options, than puts
Call options by funds: $21.2M | Put options by funds: $12.1M
67% more first-time investments, than exits
New positions opened: 50 | Existing positions closed: 30
50% more funds holding in top 10
Funds holding in top 10: 6 → 9 (+3)
26% more capital invested
Capital invested by funds: $4.19B → $5.26B (+$1.07B)
6% more funds holding
Funds holding: 308 → 325 (+17)
1.32% less ownership
Funds ownership: 53.65% → 52.33% (-1.3%)
19% less repeat investments, than reductions
Existing positions increased: 101 | Existing positions reduced: 124
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
+$94.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$39.4M |
| 3 |
WG
Winton Group
London,
United Kingdom
|
+$36M |
| 4 |
Canada Pension Plan Investment Board
Toronto Ontario,
Ontario, Canada
|
+$19.5M |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$18.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
-$76.6M |
| 2 |
CBOA
Commonwealth Bank of Australia
Sydney, NSW,
Australia
|
-$49.3M |
| 3 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
-$49M |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$48.4M |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$29.5M |
RMD Hedge Fund Activity: Q1 2015 in Review
325 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in ResMed (RMD) for Q1 2015, worth a combined $5.26B — up 26% from $4.19B a quarter earlier.
Buyers outnumbered sellers: 50 funds opened new RMD positions and 30 closed out — a net gain of 20 holders — while 101 added to existing stakes and 124 trimmed.
The largest buyer was OppenheimerFunds, adding an estimated $94.9M. The largest seller was Invesco, cutting an estimated $76.6M.
- 325 institutional investors held ResMed (RMD) as of Q1 2015, up from 308 in Q4 2014.
- Funds reported $5.26B of ResMed stock for Q1 2015, up 26% quarter-over-quarter.
- 50 funds opened new ResMed positions in Q1 2015 and 30 closed out, a net change of +20 holders.
- The largest ResMed buyer in Q1 2015 was OppenheimerFunds, an estimated $94.9M added.
- The largest ResMed seller in Q1 2015 was Invesco, an estimated $76.6M sold.
Based on aggregated 13F filings for Q1 2015.